eMedicine Specialties > Emergency Medicine > Obstetrics & Gynecology

Abortion, Incomplete

Author: Verena T Valley, MD, Associate Professor, Director of Ultrasound, Department of Emergency Medicine, University of Mississippi School of Medicine
Coauthor(s): Loretta Jackson-Williams, MD, PhD, Assistant Professor, Department of Emergency Medicine, University of Mississippi Medical Center; Christopher A Fly, MD, Assistant Professor, Department of Emergency Medicine, Medical College of Georgia
Contributor Information and Disclosures

Updated: May 30, 2006

Introduction

Background

The most common complication of pregnancy is spontaneous abortion, which occurs in an estimated 10-15% of pregnancies. Spontaneous abortions are categorized as threatened, inevitable, incomplete, complete, or missed. Spontaneous abortions can be classified further as sporadic or recurrent. By definition, an incomplete abortion is the partial expulsion of the products of conception before the 20th week of gestation.

Pathophysiology

The timing of miscarriage suggests the pathophysiology of a spontaneous abortion. Genetic anomalies (eg, trisomies); hormonal abnormalities; and infectious, immunologic, and environmental factors usually result in first-trimester pregnancy loss. Anatomic factors usually are associated with second-trimester pregnancy loss. Factor XIII deficiency and a complete or partial deficiency of fibrinogen are associated with recurrent spontaneous abortions.

Frequency

United States

Many pregnancies are not viable. According to estimates, 50% of pregnancies terminate spontaneously before the first missed menstrual period; these abortions usually are not clinically recognized. Spontaneous abortion typically is defined as a clinically recognized (ie, by blood test or ultrasound) pregnancy loss before 20 weeks' gestation.

Mortality/Morbidity

Surveillance data from 1987 through 1990 reveal a total of 1459 pregnancy-related deaths in the US. Spontaneous and induced abortions accounted for 5.6% of these deaths.

Race

Surveillance data for pregnancy-related deaths from 1987 through 1990 demonstrate more deaths due to ectopic pregnancy and spontaneous and induced abortion among African American women than among Caucasian women. Fourteen percent of pregnancy-related deaths among black women were due to ectopic pregnancies; 7% were due to abortions. Among white women, data show that 8% of pregnancy-related deaths were due to ectopic pregnancies; 4% were due to abortions.

Age

  • Age and increased parity affect a woman's risk of miscarriage. In women younger than 20 years, miscarriage occurs in an estimated 12% of pregnancies. In women older than 20 years, miscarriage occurs in an estimated 26% of pregnancies.
  • Age primarily affects the oocyte. When oocytes from young women are used to create embryos for transfer to older recipients, implantation and pregnancy rates mimic those seen in younger women. The number of miscarriages and chromosomal anomalies decreases, suggesting that the uterus is not responsible for poor outcomes in women of advanced reproductive age.

Clinical

History

Although classified as different entities, incomplete and inevitable miscarriages present in a similar clinical fashion and have similar treatment. An inevitable abortion involves continuous and progressive dilation of the cervix without expulsion of the products of conception before the 20th week of gestation.

  • The patient history should include the following:
    • Last menstrual period (LMP)
    • Estimated length of gestation
    • Ultrasound results, if previously performed
    • Bleeding (eg, degree, duration, presence/passage of tissue): Bleeding may be quantified roughly by the number of pads soaked per hour or day. An average pad absorbs approximately 20-30 mL of blood.

Physical

  • Vital signs should be within reference ranges unless infection is present or hemorrhage has caused hypovolemia.
  • The abdomen usually is soft and nontender.
  • On pelvic examination, products of conception may be partially present in the uterus, may protrude from the external os, or may be present in the vagina. Bleeding and cramping usually persist.
  • The cervix appears dilated and effaced.
  • Bimanual examination reveals an enlarged and soft uterus.

Causes

  • Genetic factors
    • Approximately 5% of spontaneous abortions occur because of genetic factors.
    • Trisomy chromosomes commonly are encountered, with trisomy 16 accounting for approximately a third of chromosomal abnormalities in early pregnancy.
  • Anatomic factors: Congenital or acquired anatomic factors are reported to occur in 10-15% of women who have recurrent spontaneous abortions.
    • Congenital anatomic lesions include müllerian duct anomalies (eg, septate uterus, diethylstilbestrol [DES]-related anomalies). Müllerian duct lesions usually are found in second-trimester pregnancy loss.
    • Anomalies of the uterine artery with compromised endometrial blood flow are congenital.
    • Acquired lesions include intrauterine adhesions (ie, synechiae), leiomyoma, and endometriosis.
  • Endocrine factors
    • Endocrine factors potentially contribute to recurrent abortion in 10-20% of cases.
    • Luteal phase insufficiency (ie, abnormal corpus luteum function with insufficient progesterone production) is implicated as the most common endocrine abnormality contributing to spontaneous abortion.
    • Hypothyroidism, hypoprolactinemia, poor diabetic control, and polycystic ovarian syndrome are contributive factors in pregnancy loss.
  • Infectious factors
    • Presumed infectious etiology may be found in 5% of cases.
    • Bacterial, viral, parasitic, fungal, and zoonotic infections are associated with recurrent spontaneous abortion.
  • Immunologic factors
    • Immunologic factors may contribute in up to 60% of recurrent spontaneous abortions.
    • Both the developing embryo and the trophoblast may be considered immunologically foreign to the maternal immune system.
    • Antiphospholipid antibody syndrome generally is responsible for more second-trimester pregnancy losses than first-trimester losses.
  • Miscellaneous factors
    • Miscellaneous factors may account for up to 3% of recurrent spontaneous abortions.
    • Other contributing factors implicated in sporadic and recurrent spontaneous abortions include environment, drugs, placental abnormalities, medical illnesses, and male-related causes.

More on Abortion, Incomplete

Overview: Abortion, Incomplete
Differential Diagnoses & Workup: Abortion, Incomplete
Treatment & Medication: Abortion, Incomplete
Follow-up: Abortion, Incomplete
Multimedia: Abortion, Incomplete
References

References

  1. Abbott J, Emmans LS, Lowenstein SR. Ectopic pregnancy: ten common pitfalls in diagnosis. Am J Emerg Med. Nov 1990;8(6):515-22. [Medline].

  2. Albayram F, Hamper UM. First-trimester obstetric emergencies: spectrum of sonographic findings. J Clin Ultrasound. Mar-Apr 2002;30(3):161-77. [Medline].

  3. Bronson RA, van de Vegte GL. An unusual first-trimester sonographic finding associated with development of hydatidiform mole: the hyperechoic ovoid mass. AJR Am J Roentgenol. Jan 1993;160(1):137-8. [Medline].

  4. Cetin A, Cetin M. Diagnostic and therapeutic decision-making with transvaginal sonography for first trimester spontaneous abortion, clinically thought to be incomplete or complete. Contraception. Jun 1998;57(6):393-7. [Medline].

  5. Dart R, Howard K. Subclassification of indeterminate pelvic ultrasonograms: stratifying the risk of ectopic pregnancy. Acad Emerg Med. Apr 1998;5(4):313-9. [Medline].

  6. Dart R, Dart L, Mitchell P. Normal intrauterine pregnancy is unlikely in patients who have echogenic material identified within the endometrial cavity at transvaginal ultrasonography. Acad Emerg Med. Feb 1999;6(2):116-20. [Medline].

  7. Hill JA. Sporadic and recurrent spontaneous abortion. In: Kistner RW, ed. Kistner's Gynecology: Principles and Practice. 6th ed. Mosby-Year Book;1995:330-365.

  8. Inbal A, Muszbek L. Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost. Apr 2003;29(2):171-4. [Medline].

  9. Koonin LM, MacKay AP, Berg CJ, et al. Pregnancy-related mortality surveillance--United States, 1987-1990. Mor Mortal Wkly Rep CDC Surveill Summ. Aug 8 1997;46(4):17-36. [Medline].

  10. Kutteh WH. Recurrent pregnancy loss: an update. Curr Opin Obstet Gynecol. Oct 1999;11(5):435-9. [Medline].

  11. Lockshin MD. Pregnancy loss in the antiphospholipid syndrome. Thromb Haemost. Aug 1999;82(2):641-8. [Medline].

  12. Luise V, Jermy K, Collons WP. Expectant management of incomplete, spontaneous first-trimester miscarriage: outcome according to initial ultrasound criteria and value of follow-up visits. Ultrasound Obstet Gynecol. 2002;Jun;19(6):580-2.

  13. Maslovitz S, Almog B, Mimouni GS, et al. Accuracy of diagnosis of retained products of conception after dilation and evacuation. J Ultrasound Med. Jun 2004;23(6):749-56; quiz 758-9. [Medline].

  14. Molnar AM, Oliver LM, Geyman JP. Patient preferences for management of first-trimester incomplete spontaneous abortion. J Am Board Fam Pract. Sep-Oct 2000;13(5):333-7. [Medline].

  15. Munyer TP, Callen PW, Filly RA, et al. Further observations on the sonographic spectrum of gestational trophoblastic disease. J Clin Ultrasound. Sep 1981;9(7):349-58. [Medline].

  16. Nadukhovskaya L, Dart R. Emergency management of the nonviable intrauterine pregnancy. Am J Emerg Med. Oct 2001;19(6):495-500. [Medline].

  17. Nyberg DA, Hughes MP, Mack LA, Wang KY. Extrauterine findings of ectopic pregnancy of transvaginal US: importance of echogenic fluid. Radiology. Mar 1991;178(3):823-6. [Medline].

  18. Oh JS, Wright G, Coulam CB. Gestational sac diameter in very early pregnancy as a predictor of fetal outcome. Ultrasound Obstet Gynecol. Sep 2002;20(3):267-9. [Medline].

  19. Sadan O, Golan A, Girtler O, et al. Role of sonography in the diagnosis of retained products of conception. J Ultrasound Med. Mar 2004;23(3):371-4. [Medline].

  20. Sairam S, Khare M, Michailidis G, Thilaganathan B. The role of ultrasound in the expectant management of early pregnancy loss. Ultrasound Obstet Gynecol. Jun 2001;17(6):506-9. [Medline].

  21. Sauer MV. Pregnancy wastage and reproductive aging: the oocyte donation model. Curr Opin Obstet Gynecol. Jun 1996;8(3):226-9. [Medline].

  22. Scott JR. Early pregnancy loss. In: Danforth's Obstetrics and Gynecology. 7th ed. Lippincott-Raven Publishers;1994:175-185.

  23. Scroggins KM, Smucker WD, Krishen AE. Spontaneous pregnancy loss: evaluation, management, and follow-up counseling. Prim Care. Mar 2000;27(1):153-67. [Medline].

  24. Stuart GS, Sheffield JS, Hill JB, et al. Morbidity that is associated with curettage for the management of spontaneous and induced abortion in women who are infected with HIV. Am J Obstet Gynecol. Sep 2004;191(3):993-7. [Medline].

Further Reading

Keywords

miscarriage, spontaneous abortion, incomplete abortion, pregnancy loss, threatened abortion, inevitable abortion, complete abortion, missed abortion

Contributor Information and Disclosures

Author

Verena T Valley, MD, Associate Professor, Director of Ultrasound, Department of Emergency Medicine, University of Mississippi School of Medicine
Verena T Valley, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Coauthor(s)

Loretta Jackson-Williams, MD, PhD, Assistant Professor, Department of Emergency Medicine, University of Mississippi Medical Center
Loretta Jackson-Williams, MD, PhD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Christopher A Fly, MD, Assistant Professor, Department of Emergency Medicine, Medical College of Georgia
Christopher A Fly, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Medical Editor

Roy Alson, MD, PhD, FACEP, FAAEM, Associate Professor, Department of Emergency Medicine, Wake Forest University School of Medicine; Medical Director, Forsyth County EMS; Deputy Medical Advisor, North Carolina Office of EMS; Associate Medical Director, North Carolina Baptist AirCare
Roy Alson, MD, PhD, FACEP, FAAEM is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, National Association of EMS Physicians, North Carolina Medical Society, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Mark Zwanger, MD, MBA, Assistant Professor, Department of Emergency Medicine, Thomas Jefferson University
Mark Zwanger, MD, MBA is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and American Medical Association
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Pamela L Dyne, MD, Associate Professor, Program Director, Department of Medicine, Division of Emergency Medicine, University of California at Los Angeles School of Medicine
Pamela L Dyne, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
RELATED MEDSCAPE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.